Verastem, Inc. (NASDAQ: VSTM) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT VERASTEM, INC.

Verastem, Inc. (NASDAQ: VSTM)
Listen to this Section


$3.78
-0.0850 ( -2.20% ) 990.8K

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Market Data


Open $3.78
Previous Close $3.86
Volume 990.8K
Market Cap $318.10M
Day Range $3.77 - $3.99
52 Week Range $3.58 - $11.25
Shares Outstanding 87.87M
Change % -2.20%
Net Change ▼ -0.0850
Insider Ownership 0.00%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2012
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -233,072.00

Date Type Amount Purchased Purchaser
2024-08-07 Sale -3245.00 Paterson Dan
2024-07-11 Sale -7.00 Calkins Daniel
2024-06-26 Sale -28.00 Calkins Daniel
2024-06-20 Sale -8333.00 Kapur Anil
2024-06-20 Sale -593.00 Stuglik Brian M
2024-06-20 Sale -244.00 Paterson Dan
2024-06-20 Sale -8333.00 Tollefson Karin Anna
2024-06-20 Sale -38850.00 Calkins Daniel
2024-06-20 Sale -8333.00 ROBERTSON MICHELLE
2024-06-20 Sale -283.00 Gagnon Robert E.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 68 Sep 08, 2025
8-k 8K-related 13 Aug 13, 2025
10-q Quarterly Reports 109 Aug 07, 2025
4 Insider transactions 1 Aug 06, 2025
4 Insider transactions 1 Jun 24, 2025
4 Insider transactions 1 Jun 24, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
8-k 8K-related 52 Jun 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy